EPA v. Cytokinetics Inc (Biotech Research Company) ESA
Final Order With Penalty
Case summary
The U.S. Environmental Protection Agency ( EPA ) is authorized to enter into this Expedited Settlement Agreement ( Agreement ) pursuant to Section 3008 of the Resource Conservation and Recovery Act ( RCRA ) and 40 C.F.R. Section 22.13(b). EPA alleges that Cytokinetics Inc (Biotech Research Company) ( Respondent ) violated the requirements, requiring the respondent to submit a 2021 Biennial Report on March 1, 2022. Cytokinetics Inc (Biotech Research Company) failed in violation of 22 CCR Section 66262.41 [40 Code of Federal Regulations ( CFR ) Section 262.41].
Defendants (1)
- Cytokinetics Inc (Biotech Research Company)Named in complaintNamed in settlement
Facilities (1)
CYTOKINETICS, INC
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080-4808
Registry ID: 110012238373
Statutes cited
- RCRA 3008A — Compliance Order: Injunctive & Penalty
Enforcement conclusions (1)
Cytokinetics Inc (Biotech Research Company) ESAentered 2023-12-07
Primary law: RCRA
Federal penalty: $2,500
Timeline (4 milestones)
- 2023-12-07Final Order Issued
- 2023-12-07Enforcement Action Closed
- 2023-12-07Complaint Filed/Proposed Order
- 2023-12-11Enforcement Action Data Entered
Case metadata
- EPA activity ID
- 3603807684
- Case number
- 09-2024-5014
- Lead agency
- EPA
- EPA region
- 09
- Voluntary self-disclosure
- No
- Primary statute
- Compliance Order: Injunctive & Penalty
Sourced verbatim from EPA ECHO Enforcement Case Report for case 09-2024-5014 . Bulk data: ICIS-FEC download summary.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.